Article
Prognostic and Predictive Value of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutant Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors: A Single-Center Retrospective Study with Subgroup Analysis of 19del vs. L858R
2026-04-02
Abstract excerpt
<title>Abstract</title> <p>Background Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are the standard first-line treatment for EGFR-mutant lung adenocarcinoma. However, the efficacy and prognosis vary significantly among individuals. This study aimed to investigate the correlation between baseline 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) me...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3e8600de-adc1-592a-bebc-e01a6d8dce1d
- DOI
- 10.21203/rs.3.rs-9240616/v1
